LRG1

From Wikipedia, the free encyclopedia


Leucine-rich alpha-2-glycoprotein 1
Identifiers
Symbol(s) LRG1; HMFT1766; LRG
External IDs MGI1924155 HomoloGene36468
Orthologs
Human Mouse
Entrez 116844 76905
Ensembl ENSG00000171236 ENSMUSG00000037095
Uniprot P02750 n/a
Refseq NM_052972 (mRNA)
NP_443204 (protein)
NM_029796 (mRNA)
NP_084072 (protein)
Location Chr 19: 4.48 - 4.49 Mb Chr 17: 55.71 - 55.72 Mb
Pubmed search [1] [2]

Leucine-rich alpha-2-glycoprotein 1, also known as LRG1, is a human gene.[1]


[edit] References

[edit] Further reading

  • Li X, Miyajima M, Jiang C, Arai H (2007). "Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus.". Neurosci. Lett. 413 (2): 141–4. doi:10.1016/j.neulet.2006.11.039. PMID 17194537. 
  • Ramachandran P, Boontheung P, Xie Y, et al. (2006). "Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry.". J. Proteome Res. 5 (6): 1493–503. doi:10.1021/pr050492k. PMID 16740002. 
  • Cummings C, Walder J, Treeful A, Jemmerson R (2006). "Serum leucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay.". Apoptosis 11 (7): 1121–9. doi:10.1007/s10495-006-8159-3. PMID 16699948. 
  • Liu T, Qian WJ, Gritsenko MA, et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.". J. Proteome Res. 4 (6): 2070–80. doi:10.1021/pr0502065. PMID 16335952. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Yamada S, Ohira M, Horie H, et al. (2004). "Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.". Oncogene 23 (35): 5901–11. doi:10.1038/sj.onc.1207782. PMID 15221005. 
  • Bunkenborg J, Pilch BJ, Podtelejnikov AV, Wiśniewski JR (2004). "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.". Proteomics 4 (2): 454–65. doi:10.1002/pmic.200300556. PMID 14760718. 
  • Anderson NL, Polanski M, Pieper R, et al. (2004). "The human plasma proteome: a nonredundant list developed by combination of four separate sources.". Mol. Cell Proteomics 3 (4): 311–26. doi:10.1074/mcp.M300127-MCP200. PMID 14718574. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • O'Donnell LC, Druhan LJ, Avalos BR (2002). "Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation.". J. Leukoc. Biol. 72 (3): 478–85. PMID 12223515. 
  • Saito K, Tanaka T, Kanda H, et al. (2002). "Gene expression profiling of mucosal addressin cell adhesion molecule-1+ high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker.". J. Immunol. 168 (3): 1050–9. PMID 11801638. 
  • Takahashi N, Takahashi Y, Putnam FW (1985). "Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum.". Proc. Natl. Acad. Sci. U.S.A. 82 (7): 1906–10. PMID 3856868.